Indicações e interpretação de resultados de testes de RNA-HPV
Referências
Valença JE, Gonçalves AK, Guerreiro da Silva ID, Eleutério Junior J, Tenório da Silva T, Bruneska D, Ximenes RA. High Risk HPV E6/E7 Oncoprotein Expression in Women with High Grade Squamous Intraepithelial Lesion. Rev Bras Ginecol Obstet. 2016 Mar;38(3):154-9. doi: 10.1055/s-0036-1580713. Epub 2016 Mar 29. PMID: 27022787.
Gupta S, Kumar P, Das BC. HPV: Molecular pathways and targets. Curr Probl Cancer. 2018 Mar-Apr;42(2):161-174. doi: 10.1016/j.currproblcancer.2018.03.003. Epub 2018 Apr 5. PMID: 29706467.
Lourenço de Freitas N, Deberaldin MG, Gomes D, Pavan AR, Sousa Â, Dos Santos JL, Soares CP. Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus. Front Cell Dev Biol. 2021 Jan 28;8:592868. doi: 10.3389/fcell.2020.592868. PMID: 33634093; PMCID: PMC7901962.
Wise-Draper TM, Wells SI. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci. 2008 Jan 1;13:1003-17. doi: 10.2741/2739. PMID: 17981607.
Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, and Lawson HW. 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower Genital Tract Disease. 2013; 17 (5):S1-S27.
